Skip to main content

Table 3 Univariate and multivariate analyses of local control

From: Treatment outcomes of stereotactic body radiation therapy for primary and metastatic sarcoma of the spine

Variables

Univariate

Multivariate

1-year rate (%)

p-value

HR

95% CI

p-value

Gender

 Men

89.8

0.062

   

 Women

63.5

    

Age (year)

 ≤ 40

81.0

0.955

   

 > 40

79.7

    

Histology

 Osteosarcoma

77.4

0.393

   

 Others

75.8

    

Spinal disease status

 Primary

100.0

0.079

   

 Metastasis

77.8

    

Any prior radiotherapy

 Yes

100.0

0.854

   

 No

75.7

    

Any prior surgery

 Yes

79.8

0.297

   

 No

75.6

    

Time from initial diagnosis (month, continuous)

0.811

   

Site of lesions

 Cervical

63.6

0.184

   

 Thoracic

85.3

    

 Lumbar

71.8

    

 Sacral

71.4

    

Treated vertebral level

 Single

80.9

 < 0.001

1

 

0.032

 2–3

60.0

 

3.031

1.098–8.365

 

BED (Gy5, continuous)

0.031

   

PTV (cc, continuous)

0.747

   

Extent of disease at the time of treatment

 Solitary spine involvement

73.3

0.560

   

 Multiple bone metastases

72.7

    

 Visceral metastases

77.2

    
  1. HR hazard ratio, CI confidence interval, BED biological equivalent dose, PTV planning target volume